Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations-Reference-Cited by-同舟云学术

Discrepant Assessments of Progressive Disease in Clinical Trials between Routine Clinical Reads and Formal RECIST 1.1 Interpretations

Published:2023-09-01 Issue:5 Volume:5 Page:
ISSN:2638-616X
Container-title:Radiology: Imaging Cancer
language:en
Short-container-title:Radiology: Imaging Cancer

Author:

Siegel Marilyn J.¹^ORCID,Ippolito Joseph E.¹^ORCID,Wahl Richard L.¹^ORCID,Siegel Barry A.¹

Affiliation:

1. From the Edward Mallinckrodt Institute of Radiology and Alvin J. Siteman Cancer Center, Washington University School of Medicine, 510 S Kingshighway Blvd, St Louis, MO 63110.

Funder

Alvin J. Siteman Cancer Center

National Cancer Institute

Publisher

Radiological Society of North America (RSNA)

Subject

Oncology,Radiology, Nuclear Medicine and imaging

Link

http://pubs.rsna.org/doi/pdf/10.1148/rycan.230001

Reference20 articles.

1. New Guidelines to Evaluate the Response to Treatment in Solid Tumors

2. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

3. Individual patient data analysis to assess modifications to the RECIST criteria

4. Lessons learned from independent central review

5. RECIST revised: implications for the radiologist. A review article on the modified RECIST guideline

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging-Based Disease Assessment and Management Recommendations: Impact of Multidisciplinary Sarcoma Tumor Board;Cancers;2024-07-26

2. Novel Therapies in Cancer: Trials and Tribulations;Clinical Cancer Research;2024-07-08

3. Tumor Response Evaluation Using iRECIST: Feasibility and Reliability of Manual Versus Software-Assisted Assessments;Cancers;2024-02-29

4. Artificial Intelligence-powered automatic volume calculation in medical images – available tools, performance and challenges for nuclear medicine;Nuklearmedizin - NuclearMedicine;2023-11-23

5. Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations?;Radiology: Imaging Cancer;2023-09-01